Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Persistency of Pseudomonas aeruginosa in sputum cultures and clinical outcomes in adult patients with cystic fibrosis.

Burkett A, Vandemheen KL, Giesbrecht-Lewis T, Ramotar K, Ferris W, Chan F, Doucette S, Fergusson D, Aaron SD.

Eur J Clin Microbiol Infect Dis. 2012 Jul;31(7):1603-10. doi: 10.1007/s10096-011-1483-8. Epub 2011 Nov 23.

PMID:
22108844
[PubMed - indexed for MEDLINE]
2.

Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.

Knudsen PK, Olesen HV, Høiby N, Johannesson M, Karpati F, Laerum BN, Meyer P, Pressler T, Lindblad A; Scandinavian CF Study Consortium (SCFSC).

J Cyst Fibros. 2009 Mar;8(2):135-42. doi: 10.1016/j.jcf.2008.11.001. Epub 2009 Jan 20.

PMID:
19157995
[PubMed - indexed for MEDLINE]
Free Article
3.

Application of quantitative PCR to the diagnosis and monitoring of Pseudomonas aeruginosa colonization in 5-18-year-old cystic fibrosis patients.

Billard-Pomares T, Herwegh S, Wizla-Derambure N, Turck D, Courcol R, Husson MO.

J Med Microbiol. 2011 Feb;60(Pt 2):157-61. doi: 10.1099/jmm.0.023838-0. Epub 2010 Oct 14.

PMID:
20947668
[PubMed - indexed for MEDLINE]
Free Article
4.

Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.

Bradbury R, Champion A, Reid DW.

Respirology. 2008 Nov;13(6):886-92. doi: 10.1111/j.1440-1843.2008.01383.x.

PMID:
18811887
[PubMed - indexed for MEDLINE]
5.

Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis.

Grimwood K, Semple RA, Rabin HR, Sokol PA, Woods DE.

Pediatr Pulmonol. 1993 Mar;15(3):135-9.

PMID:
8327274
[PubMed - indexed for MEDLINE]
6.

Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.

Hansen CR, Pressler T, Koch C, Høiby N.

J Cyst Fibros. 2005 Mar;4(1):35-40.

PMID:
15752679
[PubMed - indexed for MEDLINE]
Free Article
7.

Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures.

Zemanick ET, Wagner BD, Harris JK, Wagener JS, Accurso FJ, Sagel SD.

Pediatr Pulmonol. 2010 Jun;45(6):569-77. doi: 10.1002/ppul.21221.

PMID:
20503282
[PubMed - indexed for MEDLINE]
Free PMC Article
8.
9.

Pseudomonas hyperimmune globulin passive immunotherapy for pulmonary exacerbations in cystic fibrosis.

Van Wye JE, Collins MS, Baylor M, Pennington JE, Hsu YP, Sampanvejsopa V, Moss RB.

Pediatr Pulmonol. 1990;9(1):7-18.

PMID:
1697059
[PubMed - indexed for MEDLINE]
10.

Levofloxacin inhalation solution (MP-376) in patients with cystic fibrosis with Pseudomonas aeruginosa.

Geller DE, Flume PA, Staab D, Fischer R, Loutit JS, Conrad DJ; Mpex 204 Study Group.

Am J Respir Crit Care Med. 2011 Jun 1;183(11):1510-6. doi: 10.1164/rccm.201008-1293OC. Epub 2011 Feb 25.

PMID:
21471106
[PubMed - indexed for MEDLINE]
11.

Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.

Ramsey BW, Pepe MS, Quan JM, Otto KL, Montgomery AB, Williams-Warren J, Vasiljev-K M, Borowitz D, Bowman CM, Marshall BC, Marshall S, Smith AL.

N Engl J Med. 1999 Jan 7;340(1):23-30.

PMID:
9878641
[PubMed - indexed for MEDLINE]
Free Article
12.

Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort.

Rosenfeld M, Emerson J, McNamara S, Joubran K, Retsch-Bogart G, Graff GR, Gutierrez HH, Kanga JF, Lahiri T, Noyes B, Ramsey B, Ren CL, Schechter M, Morgan W, Gibson RL; EPIC Study Group Participating Clinical Sites.

Pediatr Pulmonol. 2010 Sep;45(9):934-44. doi: 10.1002/ppul.21279.

PMID:
20597081
[PubMed - indexed for MEDLINE]
13.

Factors associated with mucoid transition of Pseudomonas aeruginosa in cystic fibrosis patients.

Martha B, Croisier D, Fanton A, Astruc K, Piroth L, Huet F, Chavanet P.

Clin Microbiol Infect. 2010 Jun;16(6):617-23. doi: 10.1111/j.1469-0691.2009.02786.x. Epub 2009 Nov 27.

PMID:
20002106
[PubMed - indexed for MEDLINE]
14.

Outcomes of adults with cystic fibrosis infected with antibiotic-resistant Pseudomonas aeruginosa.

Lechtzin N, John M, Irizarry R, Merlo C, Diette GB, Boyle MP.

Respiration. 2006;73(1):27-33. Epub 2005 Aug 17.

PMID:
16113513
[PubMed - indexed for MEDLINE]
Free Article
15.

Clinical outcome for cystic fibrosis patients infected with transmissible pseudomonas aeruginosa: an 8-year prospective study.

Jones AM, Dodd ME, Morris J, Doherty C, Govan JR, Webb AK.

Chest. 2010 Jun;137(6):1405-9. doi: 10.1378/chest.09-2406. Epub 2010 Jan 15.

PMID:
20081099
[PubMed - indexed for MEDLINE]
16.

Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis.

de Boer K, Vandemheen KL, Tullis E, Doucette S, Fergusson D, Freitag A, Paterson N, Jackson M, Lougheed MD, Kumar V, Aaron SD.

Thorax. 2011 Aug;66(8):680-5. doi: 10.1136/thx.2011.161117. Epub 2011 Jun 15.

PMID:
21680566
[PubMed - indexed for MEDLINE]
17.
18.

Evolution of Pseudomonas aeruginosa type III secretion in cystic fibrosis: a paradigm of chronic infection.

Jain M, Bar-Meir M, McColley S, Cullina J, Potter E, Powers C, Prickett M, Seshadri R, Jovanovic B, Petrocheilou A, King JD, Hauser AR.

Transl Res. 2008 Dec;152(6):257-64. doi: 10.1016/j.trsl.2008.10.003. Epub 2008 Oct 31.

PMID:
19059160
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis.

Aaron SD, Vandemheen KL, Ramotar K, Giesbrecht-Lewis T, Tullis E, Freitag A, Paterson N, Jackson M, Lougheed MD, Dowson C, Kumar V, Ferris W, Chan F, Doucette S, Fergusson D.

JAMA. 2010 Nov 17;304(19):2145-53. doi: 10.1001/jama.2010.1665.

PMID:
21081727
[PubMed - indexed for MEDLINE]
20.

Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa.

Hendry J, Butler S, Elborn JS, Govan JR, Nelson J, Shale DJ, Webb AK.

J Infect. 2000 Mar;40(2):164-70.

PMID:
10841094
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk